212 related articles for article (PubMed ID: 22436846)
1. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury.
Ussher JR; Wang W; Gandhi M; Keung W; Samokhvalov V; Oka T; Wagg CS; Jaswal JS; Harris RA; Clanachan AS; Dyck JR; Lopaschuk GD
Cardiovasc Res; 2012 May; 94(2):359-69. PubMed ID: 22436846
[TBL] [Abstract][Full Text] [Related]
2. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
3. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.
Dyck JR; Hopkins TA; Bonnet S; Michelakis ED; Young ME; Watanabe M; Kawase Y; Jishage K; Lopaschuk GD
Circulation; 2006 Oct; 114(16):1721-8. PubMed ID: 17030679
[TBL] [Abstract][Full Text] [Related]
4. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.
Stanley WC; Hernandez LA; Spires D; Bringas J; Wallace S; McCormack JG
J Mol Cell Cardiol; 1996 May; 28(5):905-14. PubMed ID: 8762030
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
[TBL] [Abstract][Full Text] [Related]
8. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
Liepinsh E; Makrecka M; Kuka J; Makarova E; Vilskersts R; Cirule H; Sevostjanovs E; Grinberga S; Pugovics O; Dambrova M
Metabolism; 2014 Jan; 63(1):127-36. PubMed ID: 24140100
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.
Bhindi R; Fahmy RG; McMahon AC; Khachigian LM; Lowe HC
J Pathol; 2012 Jun; 227(2):157-64. PubMed ID: 22344601
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.
Hopkins TA; Dyck JR; Lopaschuk GD
Biochem Soc Trans; 2003 Feb; 31(Pt 1):207-12. PubMed ID: 12546686
[TBL] [Abstract][Full Text] [Related]
12. Transduction of anti-cell death protein FNK protects isolated rat hearts from myocardial infarction induced by ischemia/reperfusion.
Arakawa M; Yasutake M; Miyamoto M; Takano T; Asoh S; Ohta S
Life Sci; 2007 May; 80(22):2076-84. PubMed ID: 17467744
[TBL] [Abstract][Full Text] [Related]
13. Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury.
Lou PH; Zhang L; Lucchinetti E; Heck M; Affolter A; Gandhi M; Kienesberger PC; Hersberger M; Clanachan AS; Zaugg M
Cardiovasc Res; 2013 Feb; 97(2):251-61. PubMed ID: 23097573
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
Bao W; Hu E; Tao L; Boyce R; Mirabile R; Thudium DT; Ma XL; Willette RN; Yue TL
Cardiovasc Res; 2004 Feb; 61(3):548-58. PubMed ID: 14962485
[TBL] [Abstract][Full Text] [Related]
15. Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species.
Fantinelli JC; Cingolani HE; Mosca SM
Cardiovasc Pathol; 2006; 15(4):179-84. PubMed ID: 16844548
[TBL] [Abstract][Full Text] [Related]
16. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
Ussher JR; Lopaschuk GD
Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress.
Sun W; Quan N; Wang L; Yang H; Chu D; Liu Q; Zhao X; Leng J; Li J
Toxicol Sci; 2016 May; 151(1):193-203. PubMed ID: 26884059
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
[TBL] [Abstract][Full Text] [Related]
19. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
20. Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.
Witham W; Yester K; O'Donnell CP; McGaffin KR
J Mol Cell Cardiol; 2012 Jul; 53(1):91-100. PubMed ID: 22507542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
